Immunome (IMNM) Soars 6.0%: Is Further Upside Left in the Stock?

  • Immunome (IMNM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.